The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
MicroRNAs 103 and 107 regulate insulin sensitivity
Open accessAbstract
Defects in insulin signalling are among the most common and earliest defects that predispose an individual to the development of type 2 diabetes. MicroRNAs have been identified as a new class of regulatory molecules that influence many biological functions, including metabolism. However, the direct regulation of insulin sensitivity by microRNAs in vivo has not been demonstrated. Here we show that the expression of microRNAs 103 and 107 (miR-103/107) is upregulated in obese mice. Silencing of miR-103/107 leads to improved glucose homeostasis and insulin sensitivity. In contrast, gain of miR-103/107 function in either liver or fat is sufficient to induce impaired glucose homeostasis. We identify caveolin-1, a critical regulator of the insulin receptor, as a direct target gene of miR-103/107. We demonstrate that caveolin-1 is upregulated upon miR-103/107 inactivation in adipocytes and that this is concomitant with stabilization of the insulin receptor, enhanced insulin signalling, decreased adipocyte size and enhanced insulin-stimulated glucose uptake. These findings demonstrate the central importance of miR-103/107 to insulin sensitivity and identify a new target for the treatment of type 2 diabetes and obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“MicroRNA inhibitors (antagomirs) targeting miR-103 and miR-107 improve insulin sensitivity and reduce adiposity in diet-induced obese mice by enhancing hepatic and peripheral insulin signaling [92].”
From Obesity: Clinical Impact, Pathophysiology, Complications, and Modern Innovations in Therapeutic Strategies (2025) · cites this paper as [92]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Self-citationCritical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760
Caveolin, a protein component of caveolae membrane coats
Rothberg, K. G., Heuser, J. E., Donzell, W. C., Ying, Y., Glenney, J. R., & Anderson, R. G. W. (1992) · Cell · doi:10.1016/0092-8674(92)90143-z · Cited by 2,259
Rational design of cationic lipids for siRNA delivery
Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822
The multiple faces of caveolae
Parton, R. G., & Simons, K. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2122 · Cited by 1,456
Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes
Muoio, D. M., & Newgard, C. B. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2327 · Cited by 1,177
MicroRNA-143 Regulates Adipocyte Differentiation
Esau, C., Kang, X., Peralta, E. R., Hanson, E. M., Marcusson, E. G., Ravichandran, L. V., Sun, Y., Koo, S., Perera, R. J., Jain, R., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400438200 · Cited by 1,023
The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance
Goossens, G. H. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.10.010 · Cited by 591
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 996
Joven, J., Espinel, E., Rull, A., Aragonès, G., Rodríguez‐Gallego, E., Camps, J., Micol, V., Herranz‐López, M., Menéndez, J. A., Borrás, I., et al. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.03.020 · Cited by 136
Clinical applications of microRNAs
Hydbring, P., & Badalian‐Very, G. (2013) · F1000Research · doi:10.12688/f1000research.2-136.v3 · Cited by 175
Nigi, L., Grieco, G. E., Ventriglia, G., Brusco, N., Mancarella, F., Formichi, C., Dotta, F., & Sebastiani, G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123705 · Cited by 128
The Emerging Role of microRNAs and Nutrition in Modulating Health and Disease
Ross, S. A., & Davis, C. D. (2014) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071813-105729 · Cited by 130
Elgharabawy, R. M., Emara, A. M., & Abu-Risha, S. E.-S. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.09.068 · Cited by 126
The Pathophysiological Role of CoA
Czumaj, A., Szrok-Jurga, S., Hebanowska, A., Turyn, J., Świerczyński, J., Śledziński, T., & Stelmańska, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239057 · Cited by 128
MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis
Su, Q., Kumar, V., Sud, N., & Mahato, R. I. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.01.009 · Cited by 127
Application of microRNAs in diabetes mellitus
Chen, H., Lan, H.-Y., Roukos, D. H., & Cho, W. C. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0544 · Cited by 124
Role of Caveolin-1 in Diabetes and Its Complications
Haddad, D., Madhoun, A. S. A., Nizam, R., & Al‐Mulla, F. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9761539 · Cited by 121
Epigenetic Regulation of Bone Remodeling and Its Impacts in Osteoporosis
Ghayor, C., & Weber, F. E. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091446 · Cited by 124
Overexpression of blood microRNAs 103a, 30b, and 29a in l -dopa–treated patients with PD
Serafin, A., Foco, L., Zanigni, S., Blankenburg, H., Picard, A., Zanon, A., Giannini, G., Pichler, I., Facheris, M., Cortelli, P., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001258 · Cited by 122
Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease
Torres, J. L., Novo‐Veleiro, I., Manzanedo, L., Alvela-Suárez, L., Macías, R., Laso, F. J., & Marcos, M. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i36.4104 · Cited by 122
Potentially Prognostic miRNAs in HPV-Associated Oropharyngeal Carcinoma
Hui, A., Lin, A., Xu, W., Waldron, L., Perez-Ordonez, B., Weinreb, I., Shi, W., Bruce, J., Huang, S.-H., O'Sullivan, B., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3572 · Cited by 114
Jiménez-Lucena, R., Rangel-Zúñiga, O. A., Alcala-Diaz, J. F., López-Moreno, J., Roncero‐Ramos, I., Molina‐Abril, H., Yubero‐Serrano, E. M., Caballero‐Villarraso, J., Delgado‐Lista, J., Castano, J. P., et al. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.05.002 · Cited by 121
A challenge for miRNA: multiple isomiRs in miRNAomics
Guo, L., & Chen, F. (2014) · Gene · doi:10.1016/j.gene.2014.04.039 · Cited by 123
Sun, L., Wan, A. H., Zhou, Z., Chen, D., Liang, H., Liu, C., Yan, S., Niu, Y., Lin, Z., Zhan, S., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-320652 · Cited by 117
Kurtz, C. L., Peck, B. C. E., Fannin, E. E., Beysen, C., Miao, J., Landstreet, S. R., Ding, S., Turaga, V., Lund, P. K., Turner, S., et al. (2014) · Diabetes · doi:10.2337/db13-1015 · Cited by 119
Lauschke, V. M., Vorrink, S. U., Moro, S. M. L., Rezayee, F., Nordling, Å., Hendriks, D. F. G., Bell, C. C., Sison‐Young, R., Park, B. K., Goldring, C. E., et al. (2016) · Hepatology · doi:10.1002/hep.28780 · Cited by 121
Lorente‐Cebrián, S., González‐Muniesa, P., Milagro, F. I., & Martínez, J. A. (2019) · Clinical Science · doi:10.1042/cs20180890 · Cited by 121
Caria, A. C. I., Nonaka, C. K. V., Pereira, C. S., Soares, M. B. P., Macambira, S. G., & Souza, B. S. D. F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113608 · Cited by 122
Liu, W., Cao, H., Cheng, Y., Chang, C., Lü, M., Jing, Y., Zhang, D., Yao, X., Duan, Z., Xia, H., et al. (2014) · Nature Communications · doi:10.1038/ncomms6684 · Cited by 114
Nicholas, L. M., Rattanatray, L., MacLaughlin, S. M., Ozanne, S. E., Kleemann, D. O., Walker, S. K., Morrison, J. L., Zhang, S., Mühlhäusler, B. S., Martin‐Gronert, M. S., et al. (2013) · The FASEB Journal · doi:10.1096/fj.13-227918 · Cited by 115
Adipogenic miRNA and meta-signature miRNAs involved in human adipocyte differentiation and obesity
Shi, C., Huang, F., Gu, X., Zhang, M., Wen, J., Wang, X., You, L., Cui, X., Ji, C., & Guo, X. (2016) · Oncotarget · doi:10.18632/oncotarget.8518 · Cited by 115
Yu, W., MCINTOSH, C. E., Lister, R., Zhu, I., Han, Y., Ren, J., Landsman, D., Lee, E. Y., Briones, V. R., Terashima, M., et al. (2014) · Genome Research · doi:10.1101/gr.172015.114 · Cited by 115
MicroRNAs and Type 2 Diabetes/Obesity
Dehwah, M. A. S., Xu, A., & Huang, Q. (2011) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2011.11.007 · Cited by 114
Epigenetics and obesity cardiomyopathy: From pathophysiology to prevention and management
Zhang, Y., & Ren, J. T. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.03.005 · Cited by 109
Oligonucleotide Therapeutics: Chemistry, Delivery and Clinical Progress
Sharma, V. K., & Watts, J. K. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.144 · Cited by 112
Lin, X., Luo, J., Zhang, L.-P., Wang, W., Shi, H., & Zhu, J. (2013) · Gene · doi:10.1016/j.gene.2013.03.050 · Cited by 110
The Impact of Adipose Tissue–Derived miRNAs in Metabolic Syndrome, Obesity, and Cancer
Cardoso, G. S. H. R., Corrêa, L. H., & Magalhães, K. G. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.563816 · Cited by 113
D'Amore, S., Vacca, M., Cariello, M., Graziano, G., D'Orazio, A., Salvia, R., Sasso, R. C., Sabbà, C., Palasciano, G., & Moschetta, A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.07.003 · Cited by 107
dos Santos, J. M., Moreli, M. L., Tewari, S., & Benite‐Ribeiro, S. A. (2015) · Metabolism · doi:10.1016/j.metabol.2015.09.013 · Cited by 108
Epigenetic regulation of hepatocellular carcinoma in non-alcoholic fatty liver disease
Tian, Y., Wong, V. W., Chan, H. L., & Cheng, A. S. L. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.08.010 · Cited by 108
MiR-155 Enhances Insulin Sensitivity by Coordinated Regulation of Multiple Genes in Mice
Lin, X., Qin, Y., Jia, J.-S., Lin, T., Lin, X., Chen, L., Zeng, H., Han, Y., Wu, L., Huang, S., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006308 · Cited by 107
Vogel, P., Schneider, M. F., Wettengel, J., & Stafforst, T. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201402634 · Cited by 108
Lipid nanocarriers for microRNA delivery
Scheideler, M., Vidaković, I., & Prassl, R. (2019) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2019.104837 · Cited by 111
MicroRNA and vascular remodelling in acute vascular injury and pulmonary vascular remodelling
McDonald, R. A., Hata, A., MacLean, M. R., Morrell, N. W., & Baker, A. H. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr299 · Cited by 108
MicroRNAs Are Required for the Feature Maintenance and Differentiation of Brown Adipocytes
Kim, H.-J., Cho, H., Alexander, R., Patterson, H. C., Gu, M., Lo, K. A., Xu, D., Goh, V. J., Nguyen, L. N., Chai, X., et al. (2014) · Diabetes · doi:10.2337/db14-0466 · Cited by 107
Self-citationMeißburger, B., Ukropec, J., Roeder, E., Beaton, N., Geiger, M., Teupser, D., Civan, B., Langhans, W., Nawroth, P. P., Gašperíková, D., et al. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100172 · Cited by 108
Early determinants of type-2 diabetes
Berends, L. M., & Ozanne, S. E. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2012.03.002 · Cited by 101
MiR-103 Controls Milk Fat Accumulation in Goat (Capra hircus) Mammary Gland during Lactation
Lin, X., Luo, J., Zhang, L., Wang, W., & Gou, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079258 · Cited by 101
Carolan, E., Hogan, A. E., Corrigan, M. A., Gaotswe, G., O’Connell, J., Foley, N. H., O'Neill, L. A. J., Cody, D., & O'Shea, D. B. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3529 · Cited by 102
microRNA in Cardiovascular Aging and Age-Related Cardiovascular Diseases
de Lucia, C., Komici, K., Borghetti, G., Femminella, G. D., Bencivenga, L., Cannavò, A., Corbi, G., Ferrara, N., Houser, S. R., Koch, W. J., et al. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00074 · Cited by 106
The Emerging Role of MicroRNAs in the Regulation of Gene Expression by Nutrients
García-Segura, L., Pérez-Andrade, M. E., & Miranda‐Ríos, J. (2013) · Lifestyle Genomics · doi:10.1159/000345826 · Cited by 101
Early Life Nutrition and Energy Balance Disorders in Offspring in Later Life
Reynolds, C. M., Gray, C. L., Li, M., Segovia, S. A., & Vickers, M. H. (2015) · Nutrients · doi:10.3390/nu7095384 · Cited by 105
Vacca, M., Eusanio, M. D., Cariello, M., Graziano, G., D’Amore, S., Petridis, F. D., D’Orazio, A., Salvatore, L., Tamburro, A., Folesani, G., et al. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv266 · Cited by 99
Interplay of mitochondrial metabolism and microRNAs
Geiger, J., & Dalgaard, L. T. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2342-7 · Cited by 101
Chen, Z. B., Shentu, T., Wen, L., Johnson, D. A., & Shyy, J. Y.-J. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4803 · Cited by 99
Profiles of Circulating miRNAs Following Metformin Treatment in Patients with Type 2 Diabetes
Demirsoy, İ. H., Ertural, D. Y., Balcı, Ş., Çınkır, Ü., Sezer, K., Tamer, L., & Aras, N. (2018) · Journal of Medical Biochemistry · doi:10.2478/jomb-2018-0009 · Cited by 98
Altered Circulating miRNA Expression Profile in Pregestational and Gestational Obesity
Carreras‐Badosa, G., Bonmatí, A., Ortega, F. J., Mercader, J. M., Guindo-Martínez, M., Torrents, D., Prats‐Puig, A., Martínez‐Calcerrada, J., Platero-Gutierrez, E., de Zegher, F., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2872 · Cited by 93
Sacco, J., & Adeli, K. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283534c9f · Cited by 99
Are targeted therapies for diabetic cardiomyopathy on the horizon?
Tate, M., Grieve, D., & Ritchie, R. H. (2017) · Clinical Science · doi:10.1042/cs20160491 · Cited by 96
Epigenetic reprogramming in liver fibrosis and cancer
Wilson, C. L., Mann, D. A., & Borthwick, L. A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.10.011 · Cited by 98
Small Things Matter: Relevance of MicroRNAs in Cardiovascular Disease
Peters, L. J. F., Biessen, E. A. L., Hohl, M., Weber, C., van der Vorst, E. P. C., & Santovito, D. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00793 · Cited by 101
MicroRNAs as therapeutic targets for the treatment of diabetes mellitus and its complications
Regazzi, R. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1420168 · Cited by 97
Osés, M., Sánchez, J. M., Portillo, M. P., Aguilera, C. M., & Labayen, I. (2019) · Nutrients · doi:10.3390/nu11122890 · Cited by 92
Regulatory microRNAs in Brown, Brite and White Adipose Tissue
Gharanei, S., Shabir, K., Brown, J. E. P., Weickert, M. O., Barber, T. M., Kyrou, I., & Randeva, H. S. (2020) · Cells · doi:10.3390/cells9112489 · Cited by 100
Can metabolically healthy obesity be explained by diet, genetics, and inflammation?
Navarro, E., Funtikova, A. N., Fitó, M., & Schröder, H. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400521 · Cited by 92
Diabetic cardiomyopathy and metabolic remodeling of the heart
Battiprolu, P. K., Lopez-Crisosto, C., Wang, Z. V., Nemchenko, A., Lavandero, S., & Hill, J. A. (2013) · Life Sciences · doi:10.1016/j.lfs.2012.10.011 · Cited by 91
Godo, S., & Shimokawa, H. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.019 · Cited by 92
The emerging role of microRNAs in bone remodeling and its therapeutic implications for osteoporosis
Feng, Q., Zheng, S., & Zheng, J. (2018) · Bioscience Reports · doi:10.1042/bsr20180453 · Cited by 91
Saravanan, P., Sukumar, N., Adaikalakoteswari, A., Goljan, I., Venkataraman, H., Gopinath, A., Bagias, C., Yajnik, C. S., Stallard, N., Ghebremichael-Weldeselassie, Y., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05510-7 · Cited by 91
Mennigen, J. A., Panserat, S., Larquier, M., Plagnes‐Juan, E., Médale, F., Seiliez, I., & Cassy, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038604 · Cited by 93
Zhang, Z., Wu, S., Saeed, M., Ren, Q., & Sun, C. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m082602 · Cited by 91
The clinical potential of adipogenesis and obesity-related microRNAs
Zaiou, M., Amri, H. E., & Bakillah, A. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.10.015 · Cited by 92
The role of miRNAs in insulin resistance and diabetic macrovascular complications – A review
Mageed, S. S. A., Doghish, A. S., Ismail, A., El-Husseiny, A. A., Fawzi, S. F., Mahmoud, A. M. A., & El‐Mahdy, H. A. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123189 · Cited by 90
Role of miRNAs in the pathogenesis and susceptibility of diabetes mellitus
Hashimoto, N., & Tanaka, T. (2016) · Journal of Human Genetics · doi:10.1038/jhg.2016.150 · Cited by 93
Molecular mechanisms of FOXO1 in adipocyte differentiation
Chen, J., Lü, Y., Tian, M., & Huang, Q. (2019) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0178 · Cited by 91
Extra Virgin Olive Oil: Lesson from Nutrigenomics
Santis, S. D., Cariello, M., Piccinin, E., Sabbà, C., & Moschetta, A. (2019) · Nutrients · doi:10.3390/nu11092085 · Cited by 92
Role of circRNA-miRNA-mRNA interaction network in diabetes and its associated complications
Sakshi, S., Jayasuriya, R., Ganesan, K., Xu, B., & Ramkumar, K. M. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.11.007 · Cited by 92
miR-107: a Toll-like receptor-regulated miRNA dysregulated in obesity and type II diabetes
Foley, N. H., & O'Neill, L. A. J. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0312160 · Cited by 88
Blood-Based Biomarkers for Metabolic Syndrome
O’Neill, S., Bohl, M., Gregersen, S., Hermansen, K., & O’Driscoll, L. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.03.012 · Cited by 88
John, E., Wienecke-Baldacchino, A. K., Bouvy‐Liivrand, M., Heinäniemi, M., Carlberg, C., & Sinkkonen, L. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks025 · Cited by 88
Metabolic Memory and Chronic Diabetes Complications: Potential Role for Epigenetic Mechanisms
Intine, R. V. A., & Sarras, M. P. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0302-7 · Cited by 89
Du, L., Qi, R., Wang, J., Liu, Z., & Wu, Z. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212435 · Cited by 87
Ohno, M., Shibata, C., Kishikawa, T., Yoshikawa, T., Takata, A., Kojima, K., Akanuma, M., Kang, Y. J., Yoshida, H., Otsuka, M., et al. (2013) · Scientific Reports · doi:10.1038/srep02553 · Cited by 87
Gumucio, J. P., Davis, M. E., Bradley, J. R., Stafford, P. L., Schiffman, C. J., Lynch, E. B., Claflin, D. R., Bedi, A., & Mendias, C. L. (2012) · Journal of Orthopaedic Research® · doi:10.1002/jor.22168 · Cited by 87
Regulation of SIRT1 by MicroRNAs
Choi, S., & Kemper, J. K. (2013) · Molecules and Cells · doi:10.1007/s10059-013-0297-1 · Cited by 88
The miRNA Interactome in Metabolic Homeostasis
Hartig, S. M., Hamilton, M. P., Bader, D. A., & McGuire, S. E. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.09.006 · Cited by 87
MiR-26b modulates insulin sensitivity in adipocytes by interrupting the PTEN/PI3K/AKT pathway
Xu, G., Ji, C., Song, G., Zhao, C., Shi, C., Song, L., Chen, L., Yang, L., Huang, F., Pang, L., et al. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.95 · Cited by 86
Obesity, Insulin Resistance, and Colorectal Cancer: Could miRNA Dysregulation Play a Role?
Cirillo, F., Catellani, C., Sartori, C., Lazzeroni, P., Amarri, S., & Street, M. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122922 · Cited by 89
MicroRNAs as pharmacological targets in diabetes
Mao, Y., Mohan, R., Zhang, S., & Tang, X. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.06.005 · Cited by 87
MicroRNA-503 and the Extended MicroRNA-16 Family in Angiogenesis
Caporali, A., & Emanueli, C. (2011) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.05.003 · Cited by 85
MicroRNAs and Cardiovascular Diseases
Nishiguchi, T., Imanishi, T., & Akasaka, T. (2015) · BioMed Research International · doi:10.1155/2015/682857 · Cited by 83
The emerging role of micro RNA s in cardiovascular disease
Mäegdefessel, L. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12298 · Cited by 92
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits
Civelek, M., Hagopian, R., Pan, C., Che, N., Yang, W.-P., Kayne, P. S., Saleem, N. K., Cederberg, H., Kuusisto, J., Gargalovic, P. S., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt159 · Cited by 89
Zhang, Z., Zhang, T., Feng, R., Huang, H., Xia, T., & Sun, C. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.11.014 · Cited by 82
MicroRNAs miR-27a and miR-143 Regulate Porcine Adipocyte Lipid Metabolism
Wang, T., Li, M., Guan, J., Li, P., Wang, H., Guo, Y., Shuai, S., & Li, X. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12117950 · Cited by 82
MicroRNAs in bovine adipogenesis: genomic context, expression and function
Romão, J. M., Jin, W., He, M., McAllister, T. A., & Guan, L. L. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-137 · Cited by 86
Hypothalamic miR-103 Protects from Hyperphagic Obesity in Mice
Vinnikov, I. A., Hajdukiewicz, K., Reymann, J., Beneke, J., Czajkowski, R., Roth, L. C., Novak, M., Roller, A., Dörner, N., Starkuviene, V., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4251-13.2014 · Cited by 81
miRNAs link metabolic reprogramming to oncogenesis
Hatziapostolou, M., Polytarchou, C., & Iliopoulos, D. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.03.002 · Cited by 84
The Emerging Role of MitomiRs in the Pathophysiology of Human Disease
Duarte, F. V., Palmeira, C. M., & Rolo, A. P. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-22671-2_8 · Cited by 83
Green, C. J., Henriksen, T. I., Pedersen, B. K., & Solomon, T. P. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044284 · Cited by 80
Using Genome Sequence to Enable the Design of Medicines and Chemical Probes
Angelbello, A. J., Chen, J. L., Childs‐Disney, J. L., Zhang, P., Wang, Z.-F., & Disney, M. D. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00504 · Cited by 81
Huang, H., Liu, R., Zhao, G., Li, Q., Zheng, M., Zhang, J. J., Li, S. F., Liang, Z., & Wen, J. (2015) · Scientific Reports · doi:10.1038/srep16132 · Cited by 80
Li, M., Liu, Z., Zhang, Z., Liu, G., Sun, S., & Sun, C. (2014) · Biological Chemistry · doi:10.1515/hsz-2014-0241 · Cited by 80
Sangiao‐Alvarellos, S., Pena-Bello, L., Manfredi-Lozano, M., Tena‐Sempere, M., & Cordido, F. (2014) · Endocrinology · doi:10.1210/en.2013-1770 · Cited by 78
Trivellin, G., Butz, H., Delhove, J. M. K. M., Igreja, S., Chahal, H., Živković, V., McKay, T. R., Patócs, A., Grossman, A. B., & Korbonits, M. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00546.2011 · Cited by 81
Bjersing, J. L., Bokarewa, M. I., & Mannerkorpi, K. (2014) · Rheumatology International · doi:10.1007/s00296-014-3139-3 · Cited by 82
miRNA regulation of white and brown adipose tissue differentiation and function
Price, N. L., & Fernandez-Hernando, C. F. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.02.010 · Cited by 81
mirPRo–a novel standalone program for differential expression and variation analysis of miRNAs
Shi, J., Dong, M., Li, L., Liu, L., Luz-Madrigal, A., Tsonis, P. A., Rio‐Tsonis, K. D., & Liang, C. (2015) · Scientific Reports · doi:10.1038/srep14617 · Cited by 82
Metadata
- Authors
- Trajkovski, M., Hausser, J., Soutschek, J., Bhat, B., Akin, A., Zavolan, M., Heim, M. H., & Stoffel, M.
- Affiliations
- ETH Zurich (CH)
- University of Basel (CH)
- Regulus Therapeutics (United States) (US)
- University Hospital of Basel (CH)
- Corresponding author
- Stoffel, Markus
- Venue
- Nature
- Published
- 2011-06
- Volume
- 474
- Issue
- 7353
- Pages
- 649-653
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2075317528
- Cited by
- 1,000
- References
- 27
- Citations by year
- 2026: 36 · 2025: 34 · 2024: 54 · 2023: 45 · 2022: 61 · 2021: 61 · 2020: 71 · 2019: 68 · 2018: 80 · 2017: 65 · 2016: 98 · 2015: 90 · 2014: 90 · 2013: 77 · 2012: 57
- FWCI
- 25.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- BIROn (Birkbeck, University of London) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- National Science Foundation
- Juvenile Diabetes Research Foundation International
- Fondation Leducq
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- microRNA-107, insulin sensitivity, caveolin-1, insulin signaling, insulin receptor, glucose homeostasis, obesity, type 2 diabetes, adipocytes, liver, insulin-stimulated glucose uptake, adipocyte size, miRNA target genes
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Disease Models, Animal, Gene Expression Regulation, Glucose, Homeostasis, Hyperglycemia, Insulin, Liver, Male, Mice, Inbred C57BL, Signal Transduction, Up-Regulation, Gene Expression, Adipocytes, Gene Silencing, MicroRNAs, Cell Size, Caveolin 1, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review